Unlock the Future of Pharma: AI, Innovative Global Commercialization Strategies & Next Level Engagement
Pharma is undergoing significant transformation and this year's sessions will dive into the latest trends and game-changing strategies reshaping the landscape. Join us to hear from C-suite executives on navigating global commercialization and how AI is transforming the commercial model in pharma. Discover cutting-edge insights into leveraging AI for pricing and market access and explore the global potential of digital-drug combinations.
From unlocking lifesaving opportunities with systemized drug repurposing to redefining patient engagement through direct-to-patient models, these sessions will equip you with actionable strategies for driving greater business impact, increasing script lift, and boosting brand value.
Don't miss the opportunity to be part of the conversation that's setting the stage for the future of pharma commercialization strategies and more.
Here are a few of the can’t-miss sessions
- Mike Ryan - General Manager, Europe, EVERSANA
- Bhavesh Ashar - Chief Commercial Officer, SpringWorks Therapeutics
- Marc Brumagne - Global Commercial Operations HIV, Gilead
- Sharon Cunningham - Chief Executive Officer, Shorla Oncology
Transforming the Pharma Commercial Model with AI [Deep Dive]
- Scott Snyder - Chief Digital Officer, EVERSANA
- Alyssa Fenoglio - Vice President, Global Head of Digital Commercial, TEVA Pharmaceuticals
- Kimberly Noel - Global Lead of Artificial Intelligence Advocacy and Digital Health, Roche
- Karthik Parameswaran - Vice President, Strategy & Consulting Lead, Marketing, Market Access and Medical Affairs, Pfizer
AI and Pricing and Market Access [Masterclass]
Alan Crowther - General Manager, Global Pricing & Access, EVERSANA
- Ralf Jahns - Managing Director, Research2Guidance
- Nikos Green - Senior Venture Architect & PO Neuroscience, RoX Health GmbH (Roche)
The Global Opportunity for Digital-Drug Combinations within Pharma [Deep Dive]
- Farnaz Behroozi - Head of Pharma, Huma
- Pete Brockmeier - Associate Director of Digital Health Partnerships, Novo Nordisk
- Elcie Chan - EU Commercial Director for Digital Health, Otsuka
- Marty Culjat - SVP, Global Head of Digital Medicine & Regulatory Innovation, EVERSANA
- Alberta Spreafico - SVP Health Innovation, EVERSANA
Grant Mitchell - Co-Founder and CEO, Every Cure
Patient Centric 3.0: Why a Direct-to-Patient Model Is a Game Changer [Panel]
- Scott Snyder - Chief Digital Officer, EVERSANA
- Brandon Drew - Senior Vice President & Global Head, Developed Brands, UCB
- Malin Johansson - Vice President, Digital Health Partnerships and Commercialisation, Novo Nordisk
- Karthik Parameswaran - Vice President, Strategy & Consulting Lead, Marketing, Market Access and Medical Affairs, Pfizer
- Justin Chase - Executive Vice President, Media, EVERSANA INTOUCH
- Dan Feldman - General Manager, Deployment Solutions, UK, Europe and APAC, EVERSANA
- Steven Kusmanto - Global Director, Digital & Customer Engagement, Menarini
- Myles Lawless - Senior Director, Head of Digital and Omnichannel Marketing, Corcept Therapeutics
- Bram van Leeuwen - Global Digital Director Oncology, Sanofi
Revolutionizing Patient and HCP Engagement [Deep Dive]
- Paul Tunnah - Independent Consultant
- Baba Awopetu - Founder, Stragmar
- Hélène de Robien - Benelux Growth Director, Doctolib
- Valtteri Lahti - Co-founder & COO, Psyon Games
- Selwyn Learner - Founder and Creative Director, Learner Adams Bones
- Gloria Seibert - Founder and CEO, Temedica
More great sessions will be announced soon, you can always search “pharma”in the main agenda to sort all sessions around this theme at anytime.
Join us in Berlin on October 17-18, 2024, and register here!